Table 2.
EQ-5D-Y-3L (self) | EQ VAS (self) | EQ-5D-Y-3L (proxy-proxy) | EQ VAS (proxy-proxy) | EQ-5D-Y-3L (proxy-child) | EQ VAS (proxy-child) | |
---|---|---|---|---|---|---|
Overall | ||||||
N | 85 | 83 | 85 | 85 | 85 | 85 |
Median (IQR) | 1 (0.81–1) | 90 (75–98) | 0.84 (0.8–1) | 90 (85–95) | 1 (0.8–1) | 90 (90–100) |
Self vs. proxy difference (p value) | 0.32 | 0.19 | 1 | 0.01a | ||
Age group | ||||||
6–7 years | ||||||
N (%) | 30 (0.35) | 29 (0.34) | 30 (0.35) | 30 (0.35) | 30 (0.35) | 30 (0.35) |
Median (IQR) | 1 (0.76–1) | 89 (74–97) | 0.83 (0.8–1) | 90 (82–95) | 1 (0.8–1) | 90 (80–95) |
Self vs. proxy difference (p value) | 0.78 | 0.49 | 0.79 | 0.48 | ||
8–10 years | ||||||
N (%) | 30 (0.35) | 29 (0.34) | 30 (0.35) | 30 (0.35) | 30 (0.35) | 30 (0.35) |
Median (IQR) | 1 (0.76–1) | 89 (74–97) | 0.83 (0.8–1) | 90 (82–95) | 1 (0.8–1) | 90 (80–95) |
Self vs. proxy difference (p value) | 0.78 | 0.49 | 0.79 | 0.48 | ||
11–12 years | ||||||
N (%) | 32 (0.38) | 32 (0.38) | 32 (0.38) | 32 (0.38) | 32 (0.38) | 32 (0.38) |
Median (IQR) | 1 (0.83–1) | 85 (72.5–93) | 0.92 (0.8–1) | 90 (77.5–95) | 1 (0.8–1) | 90 (89–96.5) |
Self vs. proxy difference (p value) | 0.09 | 0.15 | 0.43 | 0.01a | ||
Long-term health condition/s | ||||||
No | ||||||
N (%) | 59 (0.69) | 58 (0.68) | 59 (0.69) | 59 (0.69) | 59 (0.69) | 59 (0.69) |
Median (IQR) | 1 (0.83–1) | 89.5 (75–98) | 1 (0.8–1) | 90 (85–95) | 1 (0.8–1) | 90 (88–100) |
Self vs. proxy difference (p value) | 0.84 | 0.29 | 0.48 | 0.03a | ||
Yes | ||||||
N (%) | 26 (0.31) | 25 (0.29) | 26 (0.31) | 26 (0.31) | 26 (0.31) | 26 (0.31) |
Median (IQR) | 1 (0.76–1) | 90 (75–95) | 0.8 (0.73–1) | 90 (81–95) | 0.8 (0.73–1) | 90 (90–100) |
Self vs. proxy difference (p value) | 0.18 | 0.47 | 0.3 | 0.21 |
VAS visual analogue scale, IQR interquartile range
ap value significant at α = 0.05 for the Wilcoxon matched-pair signed-rank test. EQ-5D-Y-3L, EQ VAS proxy-proxy = Proxy version 1 report; EQ-5D-Y-3L, EQ VAS proxy-child = Proxy version 2 report